Skip to main content
Clinical Trials/NCT01791439
NCT01791439
Unknown
Not Applicable

Glossopharyngeal Nerve Blockade for Awake Videolaryngoscope Assisted Endotracheal Intubation in the Morbidly Obese.

Royal Victoria Hospital, Canada1 site in 1 country24 target enrollmentJanuary 2013
ConditionsGagging

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gagging
Sponsor
Royal Victoria Hospital, Canada
Enrollment
24
Locations
1
Primary Endpoint
Gagging
Last Updated
13 years ago

Overview

Brief Summary

The investigators wish to determine if application of 2% lidocaine soaked gauze to the peritonsillar pillars will decrease the amount of gagging caused by awake videolaryngocope assisted tracheal intubation in the morbidly obese.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
April 2013
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Royal Victoria Hospital, Canada
Responsible Party
Principal Investigator
Principal Investigator

Albert Moore

Dr.

Royal Victoria Hospital, Canada

Eligibility Criteria

Inclusion Criteria

  • morbid obese patients scheduled for bariatric surgery, with a planned awake intubation.

Exclusion Criteria

  • inability to communicate in English or french
  • allergies to any study drugs
  • any patient with an American society of anesthesiologists score of 4 or more

Outcomes

Primary Outcomes

Gagging

Time Frame: 2 minutes

We will assess the amount of gagging during the awake intubation.

Secondary Outcomes

  • vital signs(2 minutes)
  • lidocaine levels(40 minutes)

Study Sites (1)

Loading locations...

Similar Trials